日本の医薬品産業プロファイルでは、市場シェア、市場規模(2017 〜 2022 年の値、および 2027 年までの予測)などのトップラインの定性的および定量的概要情報が提供されます。プロファイルには、主要な財務指標や市場内の競争圧力の分析など、主要企業の説明も含まれています。
目次
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the most recent market developments?
8 Company Profiles
8.1. Daiichi Sankyo Co Ltd
8.2. Astellas Pharma Inc.
8.3. Takeda Pharmaceutical Company Limited
8.4. Mitsubishi Tanabe Pharma Corporation
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Japan pharmaceuticals market value: $ billion, 2017-22
Table 2: Japan pharmaceuticals market geography segmentation: $ billion, 2022
Table 3: Japan pharmaceuticals market value forecast: $ billion, 2022-27
Table 4: Daiichi Sankyo Co Ltd: key facts
Table 5: Daiichi Sankyo Co Ltd: Annual Financial Ratios
Table 6: Daiichi Sankyo Co Ltd: Key Employees
Table 7: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 8: Astellas Pharma Inc.: key facts
Table 9: Astellas Pharma Inc.: Annual Financial Ratios
Table 10: Astellas Pharma Inc.: Key Employees
Table 11: Takeda Pharmaceutical Company Limited: key facts
Table 12: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
Table 13: Takeda Pharmaceutical Company Limited: Key Employees
Table 14: Takeda Pharmaceutical Company Limited: Key Employees Continued
Table 15: Mitsubishi Tanabe Pharma Corporation: key facts
Table 16: Japan size of population (million), 2018-22
Table 17: Japan gdp (constant 2005 prices, $ billion), 2018-22
Table 18: Japan gdp (current prices, $ billion), 2018-22
Table 19: Japan inflation, 2018-22
Table 20: Japan consumer price index (absolute), 2018-22
Table 21: Japan exchange rate, 2018-22
List of Figaures
Figure 1: Japan pharmaceuticals market value: $ billion, 2017-22
Figure 2: Japan pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 3: Japan pharmaceuticals market value forecast: $ billion, 2022-27
Figure 4: Forces driving competition in the pharmaceuticals market in Japan, 2022
Figure 5: Drivers of buyer power in the pharmaceuticals market in Japan, 2022
Figure 6: Drivers of supplier power in the pharmaceuticals market in Japan, 2022
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Japan, 2022
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Japan, 2022
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Japan, 2022